Diretriz para o uso dos imunobiológicos em rinossinusite crônica com pólipo nasal (RSCcPN) no Brasil
Authors:
- Wilma T. Anselmo‐LimaWAWilma T. Anselmo‐Lima
- Edwin TamashiroETEdwin Tamashiro
- Fabrizio R. RomanoFRFabrizio R. Romano
- Marcel M. MiyakeMMMarcel M. Miyake
- Renato RoithmannRRRenato Roithmann
- Eduardo M. KosugiEKEduardo M. Kosugi
- Márcio NakanishiMNMárcio Nakanishi
- Marco A. FornazieriMFMarco A. Fornazieri
- Thiago F.P. BezerraTBThiago F.P. Bezerra
- João F. Mello JrJJJoão F. Mello Jr
- Marcus M. LessaMLMarcus M. Lessa
- Richard L. VoegelsRVRichard L. Voegels
- 1 May 2022
- journal article
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology (Versão em Português)
- Vol. 88 (3) , 471-480
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Dupilumab use in recalcitrant allergic fungal rhinosinusitisAnnals of Allergy, Asthma & Immunology, 2020
- Biologics in chronic rhinosinusitis with nasal polyposisAnnals of Allergy, Asthma & Immunology, 2020
- A Phase 1, Randomized, Placebo‐Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Subcutaneous Tezepelumab in Healthy Japanese MenClinical Pharmacology in Drug Development, 2020
- Omalizumab versus intranasal steroids in the post-operative management of patients with allergic fungal rhinosinusitisEuropean Archives of Oto-Rhino-Laryngology, 2019
- A call for cost-effectiveness analysis for biologic therapies in chronic rhinosinusitis with nasal polypsAnnals of Allergy, Asthma & Immunology, 2019
- Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposisThe Laryngoscope, 2016
- Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal PolyposisJAMA, 2016
- Omalizumab therapy for refractory allergic fungal rhinosinusitis patients with moderate or severe asthmaAmerican Journal of Otolaryngology, 2015
- Olfactory outcomes in chronic rhinosinusitis with nasal polyposis after medical treatments: a systematic review and meta‐analysisInternational Forum of Allergy & Rhinology, 2014
- Nasal IL-5 levels determine the response to anti–IL-5 treatment in patients with nasal polypsJournal of Allergy and Clinical Immunology, 2006